Joshua Schafer is CCO at ZEVRA THERAPEUTICS, INC. (ZVRA). They have made 4 open-market trades across 1 company since 2023, most recently 2026-02-03.
CIK 0001945557
3 open-market purchases totalling $17K since 2023, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZVRA | 62,278 | $618K |
Shares reported on the most recent Form 4, priced at the 2026-02-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZVRA | SELL · 10b5-1 | 2026-02-03 | 2026-02-04 | $9.19 | $96K | -3.2% | +1.2% | +19.6% |
| ZVRA | SELL | 2026-01-30 | 2026-02-02 | $8.83 | $30K | -9.3% | -3.6% | +8.5% |
| ZVRA | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $7.86 | $83K | -3.0% | +4.0% | +5.0% |
| ZVRA | BUY | 2023-09-05 | 2023-09-06 | $5.13 | $3K | -0.2% | -7.8% | -0.8% |
| ZVRA | BUY | 2023-05-19 | 2023-06-30 | $5.42 | $5K | -4.9% | -4.1% | -2.7% |
| ZVRA | BUY | 2023-03-14 | 2023-03-15 | $4.61 | $9K | +19.0% | +37.4% | +27.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.